Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)
Rethinking Clinical Trials
OCTOBER 26, 2023
Fleurence, PhD, MSc Senior Advisor National Institutes of Health Joshua M. There is a lack of point-of-care diagnostics; it can take up to 3 steps to treatment initiation. The treatment is not a routine part of primary care, and there is an underserved and hard-to-reach population. Speakers Rachael L.
Let's personalize your content